Influenza News and Research

Latest Influenza News and Research

Novel amino acid mutations suggest local monkeypox transmission in Guangzhou, China

The monkeypox (mpox) virus has caused worldwide transmission since its initial report in England in early May 2022.

15 Sep 2023

Past infections may shape your COVID booster's punch against Omicron

This in-depth study examines how previous immunity impacts the effectiveness of COVID-19 booster vaccinations and susceptibility to Omicron breakthrough infections. The research highlights the significant role of individual immune histories in shaping both humoral and cellular responses to SARS-CoV-2, urging for more tailored vaccine strategies.

14 Sep 2023

UKHSA's flagship SIREN study enters new phase to continue surveillance of respiratory pathogens

The next phase of the study will be known as SIREN 2.0 and began in September 2023.

14 Sep 2023

Oral SARS-CoV-2 vaccine shows promise in monkeys

A new paper in Biology Methods and Protocols, published by Oxford University Press, indicates that researchers studying SARS-CoV-2 may have developed new methods to administer vaccines orally, which would be both easier to administer and more effective at combatting illnesses.

13 Sep 2023

COVID-19 doubles risk of early type 1 diabetes signs in high-risk children

New research in JAMA finds a temporal association between SARS-CoV-2 infections and the onset of islet autoimmunity, a precursor to type 1 diabetes, in genetically predisposed infants. The study underscores COVID-19 as a potential risk factor for the development of this form of diabetes in young children.

13 Sep 2023

New Omicron subvariant BA.2.86: A master of immune escape but not taking over yet

Researchers have isolated a new SARS-CoV-2 Omicron subvariant, BA.2.86, revealing its ability to escape neutralizing antibodies five-fold greater than its ancestor strain. Despite its enhanced immune evasion capabilities, BA.2.86 has not shown a significant difference in spread compared to other current variants.

13 Sep 2023

Interferon-gamma essential for lung-resident memory B cell development after influenza infection

During a bout of influenza, B cells interact with other immune cells and then take different paths to defend the body.

13 Sep 2023

UC Riverside study uncovers COVID's Achilles heel

New UC Riverside research has revealed COVID's Achilles heel -; its dependence on key human proteins for its replication -; which can be used to prevent the virus from making people sick.

13 Sep 2023

Tailored online interventions to promote seasonal influenza vaccination

The efficacy of tailored online interventions in improving seasonal influenza vaccination (SIV) uptake among older adults.

13 Sep 2023

Is the coadministration of a COVID-19 vaccine with a seasonal influenza vaccine safe and efficacious?

Researchers investigated the comparative efficacy and safety of the simultaneous COVID-19 and seasonal influenza vaccination regimen compared to SARS-CoV-2 vaccination alone among healthcare workers who had received one or two COVID-19 booster doses.

12 Sep 2023

CDC recommendations for pneumococcal vaccine in adults

Updated recommendations from the CDC on the use of pneumococcal vaccines in adults in the United States.

12 Sep 2023

COPD hospitalizations rising sharply in Canada, especially among younger females

Annual hospital admissions for chronic obstructive pulmonary disease (COPD) in Canada increased 69% since 2002, especially in females and people under age 65, according to new research in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.221051.

11 Sep 2023

CDC faces dilemma over recommending new covid booster for all

A small percentage of Americans got the most recent covid-19 booster shot, and even fewer probably realize the federal government is preparing to recommend yet another shot as early as Tuesday.

11 Sep 2023

CDC advises healthcare providers on new tools to combat RSV

The CDC predicts increased activity of Respiratory Syncytial Virus (RSV) for the upcoming winter season, urging clinicians to implement new prevention tools like nirsevimab and FDA-approved vaccines for vulnerable populations. The advisory comes as RSV activity shows a changing pattern, affecting infants, children, and adults, and causing thousands of hospitalizations annually.

10 Sep 2023

New hygiene product boosts natural hand barrier against contact infection

Contact infection is among the most common ways pathogens, such as bacteria and viruses, spread from one person to another. Hand washing and disinfection are important hygiene practices to minimize the probability of catching infectious diseases.

8 Sep 2023

Annual NHS flu vaccination program for children is getting underway

The annual NHS flu vaccination program for children aged 2 to 3 years, school age children and children over 6 months with certain health conditions is getting underway. Parents will receive invites from next week.

8 Sep 2023

Onset and prognosis of post-COVID-19 condition: A 2-Year observational study

Researchers conducted a prospective cohort analysis over two years.

8 Sep 2023

Researchers characterize new SARS-CoV-2 BA.2.86 variant neutralization by monoclonal antibodies

Researchers used a SARS-CoV-2 spike protein-pseudotyped viral model to characterize BA.2.86 variant neutralization by monoclonal antibodies.

6 Sep 2023

Early viral exposure in mice weakens vaccine response, raising questions for human studies

Researchers at Washington University have demonstrated that early life exposure to multiple viruses in house mice dampens the immune response to SARS-CoV-2 vaccinations later in life. The study raises concerns about the applicability of common mouse models in immunological research, suggesting that prior pathogen exposure could be a significant variable in predicting vaccine efficacy.

5 Sep 2023

Mutational changes in Avian flu virus could increase risk of transmission to humans

A new study from researchers in China and Nottingham has discovered that a subtype of avian flu virus, endemic in poultry farms in China, is undergoing mutational changes, which could increase the risk of the disease being passed on to humans.

5 Sep 2023

Influenza News and Research

Latest Influenza News and Research

Novel amino acid mutations suggest local monkeypox transmission in Guangzhou, China

Past infections may shape your COVID booster's punch against Omicron

UKHSA's flagship SIREN study enters new phase to continue surveillance of respiratory pathogens

Oral SARS-CoV-2 vaccine shows promise in monkeys

COVID-19 doubles risk of early type 1 diabetes signs in high-risk children

New Omicron subvariant BA.2.86: A master of immune escape but not taking over yet

Interferon-gamma essential for lung-resident memory B cell development after influenza infection

UC Riverside study uncovers COVID's Achilles heel

Tailored online interventions to promote seasonal influenza vaccination

Is the coadministration of a COVID-19 vaccine with a seasonal influenza vaccine safe and efficacious?

CDC recommendations for pneumococcal vaccine in adults

COPD hospitalizations rising sharply in Canada, especially among younger females

CDC faces dilemma over recommending new covid booster for all

CDC advises healthcare providers on new tools to combat RSV

New hygiene product boosts natural hand barrier against contact infection

Annual NHS flu vaccination program for children is getting underway

Onset and prognosis of post-COVID-19 condition: A 2-Year observational study

Researchers characterize new SARS-CoV-2 BA.2.86 variant neutralization by monoclonal antibodies

Early viral exposure in mice weakens vaccine response, raising questions for human studies

Mutational changes in Avian flu virus could increase risk of transmission to humans

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Influenza News and Research

Latest Influenza News and Research

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Newsletters you may be interested in